Journal article
Persistent chlamydial infections: role in inflammation and challenges for vaccine development
Mucosal Immunology Update, Vol.13(4), pp.4-7
2005
Abstract
The development of chlamydial vaccines continues to be a major challenge for researchers. While acute infections are the main target of vaccine development groups, Chlamydia is well known for its ability to establish chronic or persistent infections in its host. To date, little effort has focussed specifically on the challenges of vaccines to successfully combat the chronic or persistent phase of the disease and yet this will be a necessary aspect of any fully successful chlamydial vaccine. This short review specifically examines the phenomenon of chlamydial persistence and the unique challenges that this brings to vaccine development.
Details
- Title
- Persistent chlamydial infections: role in inflammation and challenges for vaccine development
- Authors
- Louise M Hafner (Author)Peter Timms (Author)
- Publication details
- Mucosal Immunology Update, Vol.13(4), pp.4-7
- Publisher
- Society for Mucosal Immunology
- Date published
- 2005
- ISSN
- 1068-7629
- Copyright note
- Copyright © 2005 Nature Publishing Group. The accepted version is reproduced here in accordance with the publishers copyright policy. The definitive version is available from http://www.nature.com/icb/
- Organisation Unit
- University of the Sunshine Coast, Queensland; Centre for Bioinnovation
- Language
- English
- Record Identifier
- 99449471602621
- Output Type
- Journal article
Metrics
78 File views/ downloads
820 Record Views